General Information of This Linker
Linker ID
LIN0AEMYV
Linker Name
CN119630431A-ADC-35-LINKER
Linker Type
Cathepsin-cleavable linker
Antibody-Linker Relation
Cleavable
Structure
Formula
C30H33N3O11S2
Isosmiles
O=C(O)C[C@H](NC([C@@H](NC(CCOCCOCCN1C(C(SC2=CC=CC=C2)=C(SC3=CC=CC=C3)C1=O)=O)=O)CO)=O)C(O)=O
InChI
InChI=1S/C30H33N3O11S2/c34-18-22(27(38)32-21(30(41)42)17-24(36)37)31-23(35)11-13-43-15-16-44-14-12-33-28(39)25(45-19-7-3-1-4-8-19)26(29(33)40)46-20-9-5-2-6-10-20/h1-10,21-22,34H,11-18H2,(H,31,35)(H,32,38)(H,36,37)(H,41,42)/t21-,22-/m0/s1
InChIKey
QBDCYFRCXBYLOU-VXKWHMMOSA-N
Pharmaceutical Properties
Molecule Weight
675.738
Polar area
208.87
Complexity
1298.131381
xlogp Value
1.0959
Heavy Count
46
Rot Bonds
20
Hbond acc
11
Hbond Donor
5
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
WO2024043319A1 24 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.043 nM
Positive CEACAM6_#84.7 expression (CEACAM6_#84.7 +++/++)
Method Description
In vitro cytotoxicity of ADCs in AsPC-1 cells.
In Vitro Model Pancreatic ductal adenocarcinoma AsPC-1 cells CVCL_0152
References
Ref 1 Antibody-drug complexes